

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.94222169 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.94222169 |
| 3 | macrophage activation involved in immune response (GO:0002281) | 5.10378219 |
| 4 | response to peptidoglycan (GO:0032494) | 5.00477275 |
| 5 | positive regulation of T cell cytokine production (GO:0002726) | 4.85858742 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.84292342 |
| 7 | detection of other organism (GO:0098543) | 4.70273801 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67402691 |
| 9 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.46796214 |
| 10 | response to host immune response (GO:0052572) | 4.46796214 |
| 11 | detection of bacterium (GO:0016045) | 4.46099087 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 4.30726095 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22138894 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.21849921 |
| 15 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.20404559 |
| 16 | regulation of autophagic vacuole assembly (GO:2000785) | 4.18151503 |
| 17 | detection of external biotic stimulus (GO:0098581) | 4.15866268 |
| 18 | leukocyte aggregation (GO:0070486) | 4.15310039 |
| 19 | neutrophil activation (GO:0042119) | 4.11726946 |
| 20 | response to host (GO:0075136) | 4.10084134 |
| 21 | response to host defenses (GO:0052200) | 4.10084134 |
| 22 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.10084134 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.08141670 |
| 24 | cellular extravasation (GO:0045123) | 4.03282195 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.91400773 |
| 26 | eosinophil chemotaxis (GO:0048245) | 3.89113432 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.88375158 |
| 28 | response to interleukin-15 (GO:0070672) | 3.83910912 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 3.82678658 |
| 30 | granulocyte activation (GO:0036230) | 3.77916619 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76151289 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.74303967 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 3.74025992 |
| 34 | macrophage activation (GO:0042116) | 3.69095700 |
| 35 | regulation of vacuole organization (GO:0044088) | 3.66785889 |
| 36 | cellular response to exogenous dsRNA (GO:0071360) | 3.65536355 |
| 37 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.59544130 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.58149220 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.55319655 |
| 40 | detection of biotic stimulus (GO:0009595) | 3.51361789 |
| 41 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.50239700 |
| 42 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.49478110 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.47733792 |
| 44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.46972224 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.46105731 |
| 46 | regulation of chronic inflammatory response (GO:0002676) | 3.45325348 |
| 47 | regulation of T cell cytokine production (GO:0002724) | 3.40151313 |
| 48 | response to type I interferon (GO:0034340) | 3.39892676 |
| 49 | negative regulation of phagocytosis (GO:0050765) | 3.37058335 |
| 50 | regulation of leukocyte degranulation (GO:0043300) | 3.35628884 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33494353 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32397797 |
| 53 | eosinophil migration (GO:0072677) | 3.31946747 |
| 54 | response to muramyl dipeptide (GO:0032495) | 3.26514196 |
| 55 | leukocyte degranulation (GO:0043299) | 3.21737581 |
| 56 | regulation of regulated secretory pathway (GO:1903305) | 3.19452847 |
| 57 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.19253299 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15015705 |
| 59 | galactose catabolic process (GO:0019388) | 3.13288811 |
| 60 | DNA deamination (GO:0045006) | 3.11704696 |
| 61 | regulation of metalloenzyme activity (GO:0048552) | 3.08573995 |
| 62 | B cell receptor signaling pathway (GO:0050853) | 3.08416707 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.07967367 |
| 64 | regulation of B cell differentiation (GO:0045577) | 3.07934268 |
| 65 | myeloid leukocyte mediated immunity (GO:0002444) | 3.07924593 |
| 66 | positive regulation of mast cell activation (GO:0033005) | 3.07881992 |
| 67 | negative regulation of innate immune response (GO:0045824) | 3.07348734 |
| 68 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06705284 |
| 69 | positive regulation of B cell differentiation (GO:0045579) | 3.06088015 |
| 70 | germinal center formation (GO:0002467) | 3.05381680 |
| 71 | respiratory chain complex IV assembly (GO:0008535) | 3.05250601 |
| 72 | carnitine metabolic process (GO:0009437) | 3.02933599 |
| 73 | regulation of activation of Janus kinase activity (GO:0010533) | 3.02844304 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95237272 |
| 75 | interferon-gamma secretion (GO:0072643) | 2.94411085 |
| 76 | phagocytosis, recognition (GO:0006910) | 2.91951783 |
| 77 | negative regulation of macroautophagy (GO:0016242) | 2.91249122 |
| 78 | regulation of T cell tolerance induction (GO:0002664) | 2.88375923 |
| 79 | oxidative phosphorylation (GO:0006119) | 2.88044004 |
| 80 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.87521670 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 2.87367650 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.87299732 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87006518 |
| 84 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.86435581 |
| 85 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.86435581 |
| 86 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.86435581 |
| 87 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.85025930 |
| 88 | positive regulation of T cell chemotaxis (GO:0010820) | 2.83872183 |
| 89 | regulation of T cell chemotaxis (GO:0010819) | 2.83872183 |
| 90 | regulation of developmental pigmentation (GO:0048070) | 2.83809878 |
| 91 | myeloid leukocyte activation (GO:0002274) | 2.82470027 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82223232 |
| 93 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.81204213 |
| 94 | ether lipid metabolic process (GO:0046485) | 2.75503156 |
| 95 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.75370196 |
| 96 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74904656 |
| 97 | response to interferon-beta (GO:0035456) | 2.74352120 |
| 98 | positive regulation by symbiont of host defense response (GO:0052509) | 2.74212171 |
| 99 | modulation by symbiont of host defense response (GO:0052031) | 2.74212171 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.74212171 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.74212171 |
| 102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.74212171 |
| 103 | modulation by symbiont of host immune response (GO:0052553) | 2.74212171 |
| 104 | platelet dense granule organization (GO:0060155) | 2.72742653 |
| 105 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.71909128 |
| 106 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.71677276 |
| 107 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.71504778 |
| 108 | signal peptide processing (GO:0006465) | 2.71459838 |
| 109 | response to protozoan (GO:0001562) | 2.70065313 |
| 110 | cellular response to interferon-beta (GO:0035458) | 2.68195503 |
| 111 | regulation of tolerance induction (GO:0002643) | 2.67966220 |
| 112 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67812515 |
| 113 | positive regulation of mast cell degranulation (GO:0043306) | 2.67812515 |
| 114 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.66937073 |
| 115 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.65550199 |
| 116 | termination of RNA polymerase III transcription (GO:0006386) | 2.65550199 |
| 117 | phagocytosis, engulfment (GO:0006911) | 2.65527353 |
| 118 | immunoglobulin mediated immune response (GO:0016064) | 2.64681105 |
| 119 | regulation of interferon-alpha production (GO:0032647) | 2.64085071 |
| 120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.63824964 |
| 121 | phagosome maturation (GO:0090382) | 2.62739666 |
| 122 | negative regulation of interleukin-6 production (GO:0032715) | 2.61178557 |
| 123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.60442206 |
| 124 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.59565285 |
| 125 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58480715 |
| 126 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.57810756 |
| 127 | regulation of vitamin metabolic process (GO:0030656) | 2.56056840 |
| 128 | cytochrome complex assembly (GO:0017004) | 2.55925795 |
| 129 | defense response to protozoan (GO:0042832) | 2.55676493 |
| 130 | neutrophil chemotaxis (GO:0030593) | 2.54854824 |
| 131 | T-helper 1 type immune response (GO:0042088) | 2.52336589 |
| 132 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51646029 |
| 133 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.50846441 |
| 134 | nucleotide salvage (GO:0043173) | 2.50762673 |
| 135 | cytidine deamination (GO:0009972) | 2.50127884 |
| 136 | cytidine metabolic process (GO:0046087) | 2.50127884 |
| 137 | cytidine catabolic process (GO:0006216) | 2.50127884 |
| 138 | negative regulation of interleukin-17 production (GO:0032700) | 2.49984404 |
| 139 | purine nucleobase biosynthetic process (GO:0009113) | 2.49484971 |
| 140 | respiratory burst (GO:0045730) | 2.47693622 |
| 141 | ribosomal small subunit assembly (GO:0000028) | 2.46713862 |
| 142 | developmental pigmentation (GO:0048066) | 2.46219453 |
| 143 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.46085964 |
| 144 | positive regulation of T cell mediated immunity (GO:0002711) | 2.45265196 |
| 145 | proteasome assembly (GO:0043248) | 2.44919872 |
| 146 | regulation of mononuclear cell migration (GO:0071675) | 2.44411026 |
| 147 | nucleobase biosynthetic process (GO:0046112) | 2.42861849 |
| 148 | oligosaccharide catabolic process (GO:0009313) | 2.42168765 |
| 149 | iron-sulfur cluster assembly (GO:0016226) | 2.40964634 |
| 150 | metallo-sulfur cluster assembly (GO:0031163) | 2.40964634 |
| 151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.40855298 |
| 152 | proline metabolic process (GO:0006560) | 2.38632025 |
| 153 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.38535506 |
| 154 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.38535506 |
| 155 | low-density lipoprotein particle remodeling (GO:0034374) | 2.36655099 |
| 156 | positive regulation of interleukin-10 production (GO:0032733) | 2.36596192 |
| 157 | regulation of pigment cell differentiation (GO:0050932) | 2.35777212 |
| 158 | purine nucleotide salvage (GO:0032261) | 2.35151636 |
| 159 | cGMP-mediated signaling (GO:0019934) | 2.35135473 |
| 160 | glycoside metabolic process (GO:0016137) | 2.34754576 |
| 161 | B cell mediated immunity (GO:0019724) | 2.32814255 |
| 162 | microglial cell activation (GO:0001774) | 2.31037965 |
| 163 | dendritic cell chemotaxis (GO:0002407) | 2.30287594 |
| 164 | cellular response to type I interferon (GO:0071357) | 2.30269009 |
| 165 | type I interferon signaling pathway (GO:0060337) | 2.30269009 |
| 166 | glycosphingolipid catabolic process (GO:0046479) | 2.29934080 |
| 167 | neutrophil activation involved in immune response (GO:0002283) | 2.29900923 |
| 168 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.29182297 |
| 169 | phospholipid scrambling (GO:0017121) | 2.28936840 |
| 170 | amino-acid betaine metabolic process (GO:0006577) | 2.28860647 |
| 171 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.28737476 |
| 172 | positive regulation of interferon-beta production (GO:0032728) | 2.28220514 |
| 173 | positive regulation of interferon-gamma production (GO:0032729) | 2.28007151 |
| 174 | coenzyme A metabolic process (GO:0015936) | 2.27857412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.83389650 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68729666 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.49684992 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41360561 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41352682 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.34730053 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.21488341 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.18927878 |
| 9 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.84528812 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.67742316 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.59915307 |
| 12 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58018384 |
| 13 | * MYC_22102868_ChIP-Seq_BL_Human | 2.54795882 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41977883 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39642289 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.28130222 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27902524 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.27335208 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.25344607 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22734123 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20462830 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.18507135 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16449748 |
| 24 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14915389 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.11747822 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08611587 |
| 27 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06576083 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05529088 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04352705 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02292540 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.99986387 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.97492714 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.97201226 |
| 34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.96829303 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.96654476 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95362601 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.92926926 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.92842149 |
| 39 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.91571071 |
| 40 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88500044 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84267236 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83285796 |
| 43 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82317623 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82301372 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78519660 |
| 46 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78309539 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77321888 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.76312085 |
| 49 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.73870043 |
| 50 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72208045 |
| 51 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.68433456 |
| 52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68153623 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67571667 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65904448 |
| 55 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.63343378 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.60142778 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60022016 |
| 58 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.59701486 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59371948 |
| 60 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59127484 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59073547 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58193778 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.55069613 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54862352 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54683959 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52770396 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52363476 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51319467 |
| 69 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51182514 |
| 70 | MYB_26560356_Chip-Seq_TH1_Human | 1.48800277 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47326275 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.45705521 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43158932 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41866668 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41434491 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.40485170 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40392439 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39581805 |
| 79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.38804643 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38222215 |
| 81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38017505 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37744290 |
| 83 | P68_20966046_ChIP-Seq_HELA_Human | 1.35828905 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35158732 |
| 85 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35107147 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30755699 |
| 87 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30611479 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29791327 |
| 89 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29485737 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28800158 |
| 91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28442410 |
| 92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27575756 |
| 93 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27333587 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27196140 |
| 95 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26823129 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25947721 |
| 97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24993157 |
| 98 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23928287 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23566852 |
| 100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22865706 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22376548 |
| 102 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.21895166 |
| 103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21528932 |
| 104 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.21330953 |
| 105 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21254203 |
| 106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21200523 |
| 107 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.20517550 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19884686 |
| 109 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.19454104 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19354576 |
| 111 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19100916 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18467402 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16923978 |
| 114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.15122930 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14107111 |
| 116 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13655665 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13404354 |
| 118 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12482859 |
| 119 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11612418 |
| 120 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11281320 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11004383 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08848240 |
| 123 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08647220 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08593082 |
| 125 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08170450 |
| 126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07591631 |
| 127 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07170672 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06453167 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04348132 |
| 130 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04347413 |
| 131 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04061260 |
| 132 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04020273 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02606104 |
| 134 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02097065 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01085655 |
| 136 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00767222 |
| 137 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00343107 |
| 138 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99450966 |
| 139 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98007046 |
| 140 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97087842 |
| 141 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96539114 |
| 142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96438238 |
| 143 | * P300_27268052_Chip-Seq_Bcells_Human | 0.95726994 |
| 144 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95007633 |
| 145 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93912638 |
| 146 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.93246174 |
| 147 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91840810 |
| 148 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91438419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 3.06545721 |
| 2 | MP0005174_abnormal_tail_pigmentation | 3.04955030 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 2.97855075 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.86201499 |
| 5 | MP0003436_decreased_susceptibility_to | 2.83258772 |
| 6 | MP0009379_abnormal_foot_pigmentation | 2.79094653 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.70328713 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.66583602 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.63997693 |
| 10 | MP0003724_increased_susceptibility_to | 2.51308365 |
| 11 | MP0005671_abnormal_response_to | 2.47962100 |
| 12 | MP0009785_altered_susceptibility_to | 2.44850537 |
| 13 | MP0003878_abnormal_ear_physiology | 2.33738736 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.33738736 |
| 15 | MP0002254_reproductive_system_inflammat | 2.30641393 |
| 16 | MP0005360_urolithiasis | 2.22133512 |
| 17 | MP0002419_abnormal_innate_immunity | 2.21213468 |
| 18 | MP0000015_abnormal_ear_pigmentation | 2.19418008 |
| 19 | MP0009278_abnormal_bone_marrow | 2.16873112 |
| 20 | MP0009840_abnormal_foam_cell | 2.10744186 |
| 21 | MP0005025_abnormal_response_to | 2.07981173 |
| 22 | MP0005451_abnormal_body_composition | 2.06653171 |
| 23 | MP0003186_abnormal_redox_activity | 2.00698609 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.98199739 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.86501513 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.81753242 |
| 27 | MP0003866_abnormal_defecation | 1.79547504 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.79232902 |
| 29 | MP0005387_immune_system_phenotype | 1.78186368 |
| 30 | MP0001790_abnormal_immune_system | 1.78186368 |
| 31 | MP0002723_abnormal_immune_serum | 1.73978666 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.72541344 |
| 33 | MP0008260_abnormal_autophagy | 1.70814876 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.70724765 |
| 35 | MP0009697_abnormal_copulation | 1.68615682 |
| 36 | MP0001800_abnormal_humoral_immune | 1.67100358 |
| 37 | MP0001853_heart_inflammation | 1.65427587 |
| 38 | MP0003303_peritoneal_inflammation | 1.59858816 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.58108262 |
| 40 | MP0000604_amyloidosis | 1.57817250 |
| 41 | MP0008469_abnormal_protein_level | 1.57680631 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.56628979 |
| 43 | MP0008004_abnormal_stomach_pH | 1.55978525 |
| 44 | MP0001819_abnormal_immune_cell | 1.55826908 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.53762055 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.52420369 |
| 47 | MP0003075_altered_response_to | 1.49613396 |
| 48 | MP0004947_skin_inflammation | 1.46718863 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.43699614 |
| 50 | MP0003828_pulmonary_edema | 1.42152782 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.38100538 |
| 52 | MP0001188_hyperpigmentation | 1.37886306 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.35536213 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.34075810 |
| 55 | MP0004381_abnormal_hair_follicle | 1.33869492 |
| 56 | MP0000371_diluted_coat_color | 1.32633485 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.30093075 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.27961296 |
| 59 | MP0000685_abnormal_immune_system | 1.27332626 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.26161210 |
| 61 | MP0003252_abnormal_bile_duct | 1.24302993 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.23433748 |
| 63 | MP0001663_abnormal_digestive_system | 1.21702220 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.19633856 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.18990350 |
| 66 | MP0003690_abnormal_glial_cell | 1.17718560 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.16897126 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.16818775 |
| 69 | MP0001764_abnormal_homeostasis | 1.16807854 |
| 70 | MP0000343_altered_response_to | 1.13687008 |
| 71 | MP0005310_abnormal_salivary_gland | 1.12656273 |
| 72 | MP0003011_delayed_dark_adaptation | 1.11970869 |
| 73 | MP0009780_abnormal_chondrocyte_physiolo | 1.10032879 |
| 74 | MP0004510_myositis | 1.06862500 |
| 75 | MP0005381_digestive/alimentary_phenotyp | 1.06514334 |
| 76 | MP0004883_abnormal_blood_vessel | 1.06483842 |
| 77 | MP0000490_abnormal_crypts_of | 1.05947126 |
| 78 | MP0001873_stomach_inflammation | 1.05681164 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 1.05506571 |
| 80 | MP0005332_abnormal_amino_acid | 1.02320102 |
| 81 | MP0003329_amyloid_beta_deposits | 1.02073213 |
| 82 | MP0000689_abnormal_spleen_morphology | 1.01641787 |
| 83 | MP0006082_CNS_inflammation | 1.01556930 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 1.01295112 |
| 85 | MP0005166_decreased_susceptibility_to | 1.00855260 |
| 86 | MP0000716_abnormal_immune_system | 1.00762601 |
| 87 | MP0008874_decreased_physiological_sensi | 1.00726799 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 1.00657812 |
| 89 | MP0002405_respiratory_system_inflammati | 0.95177245 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.94705315 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.94205391 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 0.93807899 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.93231414 |
| 94 | MP0005164_abnormal_response_to | 0.92471438 |
| 95 | MP0002398_abnormal_bone_marrow | 0.90403402 |
| 96 | MP0002429_abnormal_blood_cell | 0.90282503 |
| 97 | MP0002736_abnormal_nociception_after | 0.90152510 |
| 98 | MP0005171_absent_coat_pigmentation | 0.89251924 |
| 99 | MP0001851_eye_inflammation | 0.88274127 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.88035108 |
| 101 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.86351099 |
| 102 | MP0005075_abnormal_melanosome_morpholog | 0.86029631 |
| 103 | MP0002132_abnormal_respiratory_system | 0.85756748 |
| 104 | MP0004858_abnormal_nervous_system | 0.85027902 |
| 105 | MP0005083_abnormal_biliary_tract | 0.85011972 |
| 106 | MP0002006_tumorigenesis | 0.85004204 |
| 107 | MP0009764_decreased_sensitivity_to | 0.84888621 |
| 108 | MP0000609_abnormal_liver_physiology | 0.83887368 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 0.83813641 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.81900946 |
| 111 | MP0003763_abnormal_thymus_physiology | 0.81625044 |
| 112 | MP0002722_abnormal_immune_system | 0.80458612 |
| 113 | MP0005535_abnormal_body_temperature | 0.80058223 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.79903050 |
| 115 | MP0000858_altered_metastatic_potential | 0.79580135 |
| 116 | MP0000249_abnormal_blood_vessel | 0.79231722 |
| 117 | MP0004859_abnormal_synaptic_plasticity | 0.79193288 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.78334540 |
| 119 | MP0005397_hematopoietic_system_phenotyp | 0.78334540 |
| 120 | MP0000462_abnormal_digestive_system | 0.77791645 |
| 121 | MP0009763_increased_sensitivity_to | 0.74428150 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72079266 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.71901345 |
| 124 | MP0005390_skeleton_phenotype | 0.71133288 |
| 125 | MP0008873_increased_physiological_sensi | 0.70688199 |
| 126 | MP0000920_abnormal_myelination | 0.69718518 |
| 127 | MP0003448_altered_tumor_morphology | 0.66815501 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.63316141 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.61335878 |
| 130 | MP0005334_abnormal_fat_pad | 0.59993826 |
| 131 | MP0002971_abnormal_brown_adipose | 0.59630211 |
| 132 | MP0009115_abnormal_fat_cell | 0.56536474 |
| 133 | MP0003045_fibrosis | 0.56120647 |
| 134 | MP0002928_abnormal_bile_duct | 0.53085134 |
| 135 | MP0002970_abnormal_white_adipose | 0.52791557 |
| 136 | MP0003795_abnormal_bone_structure | 0.52635619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 4.30954773 |
| 2 | Obstructive lung disease (HP:0006536) | 4.05445197 |
| 3 | Chronic obstructive pulmonary disease (HP:0006510) | 4.05445197 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.81284561 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.75651631 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 3.75164659 |
| 7 | Meningitis (HP:0001287) | 3.69312925 |
| 8 | Gastrointestinal infarctions (HP:0005244) | 3.40430610 |
| 9 | Posterior subcapsular cataract (HP:0007787) | 3.38111225 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.35871355 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 3.25961712 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.21243866 |
| 13 | Cellulitis (HP:0100658) | 3.19643529 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 3.18243797 |
| 15 | Increased IgE level (HP:0003212) | 3.16763936 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.15544096 |
| 17 | Encephalitis (HP:0002383) | 3.14790513 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.12422861 |
| 19 | Hypochromic anemia (HP:0001931) | 3.08908920 |
| 20 | Episodic fever (HP:0001954) | 3.08326787 |
| 21 | Prolonged bleeding time (HP:0003010) | 3.06027317 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02870435 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02870435 |
| 24 | Vasculitis (HP:0002633) | 2.96807015 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.95035715 |
| 26 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.94585398 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.90226095 |
| 28 | Keratoconjunctivitis (HP:0001096) | 2.86515596 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84769230 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81723009 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81723009 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81723009 |
| 33 | Flared iliac wings (HP:0002869) | 2.74714033 |
| 34 | Hepatic necrosis (HP:0002605) | 2.72848875 |
| 35 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.72539188 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.70580855 |
| 37 | Cholecystitis (HP:0001082) | 2.65950180 |
| 38 | Abnormal gallbladder physiology (HP:0012438) | 2.65950180 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.65892982 |
| 40 | Agnosia (HP:0010524) | 2.65230411 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.63514274 |
| 42 | Methylmalonic aciduria (HP:0012120) | 2.62745162 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.61977712 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61219100 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.58426739 |
| 46 | Hyperglycinuria (HP:0003108) | 2.58026292 |
| 47 | Chest pain (HP:0100749) | 2.54761371 |
| 48 | Flat capital femoral epiphysis (HP:0003370) | 2.54393704 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53711032 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.53711032 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.53317152 |
| 52 | Osteomyelitis (HP:0002754) | 2.49300251 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.47752400 |
| 54 | Neoplasm of head and neck (HP:0012288) | 2.47511300 |
| 55 | Esophageal neoplasm (HP:0100751) | 2.47511300 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.46844615 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.43899189 |
| 58 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.42755802 |
| 59 | Vertebral hypoplasia (HP:0008417) | 2.42755802 |
| 60 | Increased IgM level (HP:0003496) | 2.41616897 |
| 61 | Stomatitis (HP:0010280) | 2.41044042 |
| 62 | Eczematoid dermatitis (HP:0000976) | 2.40948769 |
| 63 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.39933231 |
| 64 | Vertebral clefting (HP:0008428) | 2.39500766 |
| 65 | Myositis (HP:0100614) | 2.38709085 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.37800531 |
| 67 | Hemoptysis (HP:0002105) | 2.36509648 |
| 68 | Recurrent viral infections (HP:0004429) | 2.36181641 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34880884 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34880884 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34880884 |
| 72 | Exertional dyspnea (HP:0002875) | 2.34356064 |
| 73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34333521 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.34333521 |
| 75 | Arterial thrombosis (HP:0004420) | 2.33461461 |
| 76 | Epistaxis (HP:0000421) | 2.33360461 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.32861534 |
| 78 | Microvesicular hepatic steatosis (HP:0001414) | 2.31964921 |
| 79 | Neonatal short-limb short stature (HP:0008921) | 2.30954973 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.26441475 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.24935721 |
| 82 | Lymphopenia (HP:0001888) | 2.24911082 |
| 83 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.23814392 |
| 84 | Large eyes (HP:0001090) | 2.23557420 |
| 85 | Increased serum ferritin (HP:0003281) | 2.22685507 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 2.22440869 |
| 87 | Poor head control (HP:0002421) | 2.21409456 |
| 88 | 11 pairs of ribs (HP:0000878) | 2.19552741 |
| 89 | Breech presentation (HP:0001623) | 2.18541093 |
| 90 | Gingival bleeding (HP:0000225) | 2.18187983 |
| 91 | Sepsis (HP:0100806) | 2.18085682 |
| 92 | Neuronal loss in central nervous system (HP:0002529) | 2.16934382 |
| 93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.16356913 |
| 94 | Abnormality of glycine metabolism (HP:0010895) | 2.16168416 |
| 95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.16168416 |
| 96 | Prolonged neonatal jaundice (HP:0006579) | 2.15958356 |
| 97 | Mitochondrial inheritance (HP:0001427) | 2.15180948 |
| 98 | Leukocytosis (HP:0001974) | 2.14746154 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.14462065 |
| 100 | Polycythemia (HP:0001901) | 2.13360088 |
| 101 | Congenital sensorineural hearing impairment (HP:0008527) | 2.13259364 |
| 102 | Abnormality of T cells (HP:0002843) | 2.12060992 |
| 103 | Hypoplastic ilia (HP:0000946) | 2.11434520 |
| 104 | Pulmonary embolism (HP:0002204) | 2.11378499 |
| 105 | Microcytic anemia (HP:0001935) | 2.10883342 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 2.10562764 |
| 107 | Hydroxyprolinuria (HP:0003080) | 2.10562764 |
| 108 | Abnormality of T cell physiology (HP:0011840) | 2.10260367 |
| 109 | Petechiae (HP:0000967) | 2.07886539 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 2.07625057 |
| 111 | Orchitis (HP:0100796) | 2.07387357 |
| 112 | Type I transferrin isoform profile (HP:0003642) | 2.06565772 |
| 113 | Increased CSF lactate (HP:0002490) | 2.04392546 |
| 114 | Albinism (HP:0001022) | 2.04277611 |
| 115 | Colitis (HP:0002583) | 2.03766133 |
| 116 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.03527301 |
| 117 | Increased serum lactate (HP:0002151) | 2.02252163 |
| 118 | Hypermelanotic macule (HP:0001034) | 2.01632823 |
| 119 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00876062 |
| 120 | Recurrent skin infections (HP:0001581) | 1.99631289 |
| 121 | Granulocytopenia (HP:0001913) | 1.98462040 |
| 122 | Progressive neurologic deterioration (HP:0002344) | 1.98214483 |
| 123 | Generalized aminoaciduria (HP:0002909) | 1.97646435 |
| 124 | T lymphocytopenia (HP:0005403) | 1.97127172 |
| 125 | Amyloidosis (HP:0011034) | 1.95131780 |
| 126 | Vertigo (HP:0002321) | 1.94993522 |
| 127 | Loss of speech (HP:0002371) | 1.94869551 |
| 128 | Cupped ribs (HP:0000887) | 1.94470843 |
| 129 | Abnormality of the pleura (HP:0002103) | 1.94420514 |
| 130 | Pustule (HP:0200039) | 1.92796894 |
| 131 | Hypertensive crisis (HP:0100735) | 1.92501471 |
| 132 | Pancreatitis (HP:0001733) | 1.92394431 |
| 133 | Increased hepatocellular lipid droplets (HP:0006565) | 1.92128784 |
| 134 | Glomerulopathy (HP:0100820) | 1.92085847 |
| 135 | Hypertriglyceridemia (HP:0002155) | 1.91858704 |
| 136 | Retrobulbar optic neuritis (HP:0100654) | 1.91214199 |
| 137 | Optic neuritis (HP:0100653) | 1.91214199 |
| 138 | Urticaria (HP:0001025) | 1.90149520 |
| 139 | Acne (HP:0001061) | 1.88542816 |
| 140 | Glomerulonephritis (HP:0000099) | 1.88180740 |
| 141 | Polygenic inheritance (HP:0010982) | 1.87588425 |
| 142 | Neoplasm of the rectum (HP:0100743) | 1.87581192 |
| 143 | IgM deficiency (HP:0002850) | 1.87408387 |
| 144 | Purpura (HP:0000979) | 1.87215470 |
| 145 | Skin ulcer (HP:0200042) | 1.86788129 |
| 146 | Generalized hypopigmentation (HP:0007513) | 1.86517291 |
| 147 | Increased CSF protein (HP:0002922) | 1.85761138 |
| 148 | Abnormal protein glycosylation (HP:0012346) | 1.85639606 |
| 149 | Abnormal glycosylation (HP:0012345) | 1.85639606 |
| 150 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.85639606 |
| 151 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.85639606 |
| 152 | Lactic acidosis (HP:0003128) | 1.84947629 |
| 153 | Acute encephalopathy (HP:0006846) | 1.84731313 |
| 154 | Irregular epiphyses (HP:0010582) | 1.84629120 |
| 155 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83809672 |
| 156 | Anorexia (HP:0002039) | 1.83356326 |
| 157 | Abnormality of T cell number (HP:0011839) | 1.82462089 |
| 158 | Breast hypoplasia (HP:0003187) | 1.82276332 |
| 159 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81893151 |
| 160 | Splenomegaly (HP:0001744) | 1.80789593 |
| 161 | Progressive visual loss (HP:0000529) | 1.80684462 |
| 162 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.79218188 |
| 163 | Hypoplasia of the thymus (HP:0000778) | 1.77636983 |
| 164 | Methylmalonic acidemia (HP:0002912) | 1.75730895 |
| 165 | Gingivitis (HP:0000230) | 1.75487398 |
| 166 | True hermaphroditism (HP:0010459) | 1.75444006 |
| 167 | Acute hepatic failure (HP:0006554) | 1.74744342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 7.62519311 |
| 2 | BCKDK | 2.98717665 |
| 3 | BLK | 2.90777976 |
| 4 | MAP2K3 | 2.83714340 |
| 5 | MAP3K12 | 2.80597540 |
| 6 | FLT3 | 2.72196043 |
| 7 | TNK2 | 2.61403386 |
| 8 | TNIK | 2.44965818 |
| 9 | TGFBR2 | 2.42482227 |
| 10 | STK16 | 2.25791695 |
| 11 | PKN2 | 2.18158671 |
| 12 | CASK | 2.18127229 |
| 13 | IRAK4 | 2.15395168 |
| 14 | KIT | 2.11234715 |
| 15 | MAP3K14 | 2.07344111 |
| 16 | TSSK6 | 1.93826055 |
| 17 | TBK1 | 1.91578647 |
| 18 | SIK3 | 1.79506978 |
| 19 | BUB1 | 1.74433731 |
| 20 | MAP3K3 | 1.72837645 |
| 21 | TAOK1 | 1.71871354 |
| 22 | SMG1 | 1.70541764 |
| 23 | IRAK3 | 1.70165962 |
| 24 | GRK6 | 1.69460514 |
| 25 | FGR | 1.66000634 |
| 26 | SIK2 | 1.61226122 |
| 27 | LMTK2 | 1.59030099 |
| 28 | PRPF4B | 1.49493116 |
| 29 | KSR2 | 1.48887422 |
| 30 | CCNB1 | 1.47433292 |
| 31 | MAP3K1 | 1.46831675 |
| 32 | TAOK2 | 1.46776822 |
| 33 | EPHB2 | 1.44107054 |
| 34 | MAP4K1 | 1.41450677 |
| 35 | BTK | 1.34259543 |
| 36 | TYK2 | 1.32238097 |
| 37 | DAPK1 | 1.28008537 |
| 38 | NME2 | 1.24151243 |
| 39 | FES | 1.23579515 |
| 40 | ILK | 1.21640340 |
| 41 | PAK4 | 1.16530306 |
| 42 | JAK3 | 1.14791966 |
| 43 | SIK1 | 1.12845971 |
| 44 | ADRBK2 | 1.09928216 |
| 45 | TEC | 1.08204950 |
| 46 | YES1 | 1.05869596 |
| 47 | ERN1 | 1.05178295 |
| 48 | PDPK1 | 1.03839023 |
| 49 | ZAP70 | 1.03049001 |
| 50 | MYLK | 1.03008764 |
| 51 | IKBKE | 0.96242329 |
| 52 | CAMKK1 | 0.92390794 |
| 53 | PRKD2 | 0.90448503 |
| 54 | TXK | 0.89671758 |
| 55 | MARK2 | 0.89499555 |
| 56 | TESK2 | 0.88340553 |
| 57 | TLK1 | 0.88008548 |
| 58 | JAK1 | 0.87035394 |
| 59 | IRAK1 | 0.86635424 |
| 60 | MST1R | 0.86005725 |
| 61 | MAP3K5 | 0.83519864 |
| 62 | LYN | 0.83372355 |
| 63 | CSK | 0.82541488 |
| 64 | LCK | 0.81615162 |
| 65 | MATK | 0.81601556 |
| 66 | MAP2K4 | 0.80038730 |
| 67 | STK38 | 0.78948903 |
| 68 | PBK | 0.78197471 |
| 69 | PIM2 | 0.78151807 |
| 70 | MUSK | 0.74664258 |
| 71 | HIPK2 | 0.73884168 |
| 72 | IKBKB | 0.73543853 |
| 73 | MAP2K6 | 0.73280672 |
| 74 | CDK19 | 0.72863281 |
| 75 | RIPK1 | 0.72299715 |
| 76 | MAP3K11 | 0.72133246 |
| 77 | MAP3K6 | 0.71309152 |
| 78 | TGFBR1 | 0.70603525 |
| 79 | GRK7 | 0.68690308 |
| 80 | EPHA4 | 0.67237800 |
| 81 | SYK | 0.66756641 |
| 82 | MAP3K13 | 0.66018438 |
| 83 | RIPK4 | 0.65744090 |
| 84 | LRRK2 | 0.65497831 |
| 85 | NUAK1 | 0.65140790 |
| 86 | DYRK1B | 0.64626229 |
| 87 | MAP2K2 | 0.63872170 |
| 88 | FGFR4 | 0.62271118 |
| 89 | PAK6 | 0.62102895 |
| 90 | CSF1R | 0.61159758 |
| 91 | ALK | 0.60189815 |
| 92 | PIK3CG | 0.58761468 |
| 93 | NEK6 | 0.56717752 |
| 94 | ERBB2 | 0.55154482 |
| 95 | ERBB3 | 0.54643210 |
| 96 | FYN | 0.54245759 |
| 97 | STK10 | 0.52883131 |
| 98 | MAPK12 | 0.52605650 |
| 99 | MAPK7 | 0.52284580 |
| 100 | IRAK2 | 0.51952329 |
| 101 | RAF1 | 0.51309054 |
| 102 | DYRK2 | 0.50610465 |
| 103 | RET | 0.48605111 |
| 104 | BRAF | 0.46414869 |
| 105 | ACVR1B | 0.46384837 |
| 106 | PRKCZ | 0.46324842 |
| 107 | BMPR2 | 0.45669379 |
| 108 | DAPK3 | 0.45656289 |
| 109 | ARAF | 0.44830070 |
| 110 | PIK3CA | 0.43134162 |
| 111 | STK11 | 0.42802698 |
| 112 | CDC42BPA | 0.42370392 |
| 113 | EPHB1 | 0.42110004 |
| 114 | PASK | 0.41513256 |
| 115 | RPS6KC1 | 0.41401224 |
| 116 | RPS6KL1 | 0.41401224 |
| 117 | MAP3K7 | 0.41331134 |
| 118 | MARK3 | 0.41107790 |
| 119 | TRIB3 | 0.41016429 |
| 120 | PIM1 | 0.40481323 |
| 121 | MAP3K2 | 0.40091885 |
| 122 | KDR | 0.39731785 |
| 123 | PTK6 | 0.39318421 |
| 124 | PRKG2 | 0.38839683 |
| 125 | DAPK2 | 0.37794767 |
| 126 | MAPK4 | 0.36675753 |
| 127 | PAK1 | 0.36594849 |
| 128 | DYRK3 | 0.36139166 |
| 129 | JAK2 | 0.34170264 |
| 130 | PRKCD | 0.33944893 |
| 131 | PDK1 | 0.33913675 |
| 132 | MAP3K8 | 0.33654924 |
| 133 | CAMK4 | 0.32706544 |
| 134 | HCK | 0.31247147 |
| 135 | IGF1R | 0.31099968 |
| 136 | ITK | 0.31071845 |
| 137 | MAPKAPK2 | 0.30686804 |
| 138 | PRKD1 | 0.30674150 |
| 139 | SRC | 0.29541746 |
| 140 | ABL2 | 0.29095256 |
| 141 | RPS6KA2 | 0.29053225 |
| 142 | MST4 | 0.28412162 |
| 143 | MOS | 0.28379271 |
| 144 | VRK1 | 0.28063302 |
| 145 | FGFR1 | 0.27296593 |
| 146 | WEE1 | 0.25821803 |
| 147 | PRKCQ | 0.24229256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.99612946 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.94341119 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.53279820 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19459897 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.15724866 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.13980699 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.05766792 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.97871833 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 1.95787966 |
| 10 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.95525435 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88283821 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.85630918 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 1.83063410 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.80405177 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70757402 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.70273489 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69263349 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67880292 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64955252 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61813322 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58239804 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57688011 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57598409 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54706145 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.52875238 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.52019031 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.51690815 |
| 28 | Proteasome_Homo sapiens_hsa03050 | 1.49108690 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.48977435 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48308553 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.41889818 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41390363 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38986058 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.37409413 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36716941 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36502903 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35440567 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34367824 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33035654 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32323243 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32172459 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31010299 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29069630 |
| 44 | Mismatch repair_Homo sapiens_hsa03430 | 1.28603028 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.26547851 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.26286941 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25413713 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.23113251 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22292844 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18192343 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17760581 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17350541 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16863534 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16847227 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16538841 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15072921 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14564013 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12472911 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12423703 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.12285902 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12148134 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 1.11652958 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09248595 |
| 64 | Measles_Homo sapiens_hsa05162 | 1.08313213 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.08279881 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08066518 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 1.07391245 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 1.07177752 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06065954 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 1.05996769 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04625555 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03968891 |
| 73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.03814026 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03570813 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03420159 |
| 76 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02988409 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 1.00585439 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00094147 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99894661 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98319556 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97338921 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95263248 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94780700 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94608086 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93652815 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.93015467 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92764198 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92241777 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92105459 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91800008 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90762599 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.88096242 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86763908 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85992418 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.85914063 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85238938 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84667986 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84553941 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84415003 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.84094814 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.83597324 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83543172 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82819438 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82745805 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.82702295 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82393385 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.81373281 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81264368 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.81253969 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81229544 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81223279 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80219696 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79902371 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79163836 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78893620 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78335865 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78119725 |
| 118 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77430231 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75704777 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74829385 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74528882 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.74311191 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.73710241 |
| 124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72983662 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72391331 |
| 126 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70696140 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70688380 |
| 128 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70681703 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69681544 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67573851 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67185608 |
| 132 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66908158 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65956250 |
| 134 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65452195 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65175123 |
| 136 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64832976 |
| 137 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.64414359 |
| 138 | Purine metabolism_Homo sapiens_hsa00230 | 0.64314429 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64202381 |
| 140 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63370804 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.62417482 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62281813 |
| 143 | Base excision repair_Homo sapiens_hsa03410 | 0.61286185 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61144685 |
| 145 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58665038 |
| 146 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58580663 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57139789 |
| 148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56799686 |
| 149 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56725645 |
| 150 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56691585 |
| 151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56634814 |
| 152 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56451838 |
| 153 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56414369 |
| 154 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56061002 |
| 155 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54196860 |
| 156 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54134538 |
| 157 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53782217 |
| 158 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53760126 |
| 159 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52899139 |
| 160 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52447962 |
| 161 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52166766 |
| 162 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48618356 |
| 163 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47373614 |
| 164 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46534364 |
| 165 | Insulin resistance_Homo sapiens_hsa04931 | 0.44516721 |
| 166 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44233422 |

